TALENs Construction: Slowly but Surely

  • Hegazy, Wael Abdel Halim (Department of Microbiology and Immunology, Faculty of Pharmacy, Zagzig University) ;
  • Youns, Mahmoud (Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University)
  • Published : 2016.07.01


Cancer is thought to be a direct result of transcriptional misregulation. Broad analysis of transcriptional regulatory elements in healthy and cancer cells is needed to understand cancer development. Nucleases regulatory domains are recruited to bind and manipulate a specific genomic locus with high efficacy and specificity. TALENs (transcription activator-like effector nuclease) fused to endonuclease FokI have been used widely to target specific sequences to edit several genes in healthy and cancer cells. This approach is promising to target specific cancer genes and for this purpose it is needed to pack such TALENs into viral vectors. There are some considerations which control the success of this approach, targeting appropriate sequences with efficient construction of TALENs being crucial factors. We face some obstacles in construction of TALENs; in this study we made a modification to the method of Cermk et al 2011 and added one step to make it easier and increase the availability of constructs.


  1. Bibikova M, Beumer K, Trautman JK, et al (2003). Enhancing gene targeting with designed zinc finger nucleases. Science, 300, 764.
  2. Boch J and Bonas U (2010). Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol, 48, 419-36.
  3. Bonas U, Stall RE, Staskawicz B (1989). Genetic and structural characterization of the avirulence gene avrBs3 from Xanthomonas campestris pv.vesicatoria. Mol Gen Genet, 218, 127-36.
  4. Briggs AW, Rios X, Chari R, et al (2012). Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res, 40, 117.
  5. Cermak T, Doyle EL, Christian M, et al (2011). Efficient design and assembly of custom TALEN and other TAL effectorbased constructs for DNA targeting. Nucleic Acids Res, 39, 82.
  6. Cradick TJ, Ambrosini G, Iseli C, et al (2011). ZFN site searches genomes for zinc finger nuclease target sites and off-target sites. BMC Bioinformatics, 12, 152.
  7. Gaj T, Gersbach CA, Barbas CF (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol, 31, 397-405.
  8. Grimmer MR, Farnham PJ (2014). Can genome engineering be used to target cancer-associated enhancers? Epigenomics, 6, 493-501.
  9. Hockemeyer D, Wang H, Kiani S, et al (2011). Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol, 29, 731-4.
  10. Huang P, Xiao A, Zhou M, et al (2011). Heritable gene targeting in zebrafish using customized TALENs. Nat Biotechnol, 29, 699-700.
  11. Kay S, Hahn S, Marois E, et al (2007). A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science, 318, 648-51.
  12. Kumar Y, Sharma P, Bhatt N et al (2016). Transarterial therapies for hepatocellular carcinoma: a comprehensive review with current updates and future directions. Asian Pac J Cancer Prev, 17, 473-8.
  13. Li T, Huang S, Jiang WZ, et al (2011). TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNAcleavage domain. Nucleic Acids Res, 39, 359-72.
  14. Lee TI, Young RA (2013). Transcriptional regulation and its misregulation in disease. Cell, 152, 1237-51.
  15. Miller JC, Tan S, Qiao G, et al (2011). A TALE nuclease a rchitecture for efficient genome editing. Nat Biotechnol, 29, 143-8.
  16. Moscou MJ, Bogdanove AJ (2009). A simple cipher governs DNA recognition by TAL effectors. Science, 326, 1501.
  17. Perez-Pinera P, Ousterout DG, Gersbach C (2012). A. Advances in targeted genome editing. Curr Opin Chem Biol, 16, 268-77.
  18. Reyon D, Tsai SQ, Khayter C, et al (2012). FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol, 30, 460-5.
  19. Romer P, Hahn S, Jordan T, et al (2007). Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene. Science, 318, 645-8.
  20. Schmid-Burgk JL, Schmidt T, Kaiser V, et al (2013). A ligationindependent cloning technique for high-throughput assembly of transcription activator-like effector genes. Nat Biotechnol, 31, 76-81.
  21. Shearer RF, Saunders DN (2015). Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives. Genes Cells, 20, 1-10.
  22. Streubel J, Blucher C, Landgraf A et al (2012). TAL effector RVD specificities and efficiencies. Nat Biotechnol, 30, 593-5.
  23. Sun N, Zhao H (2013). Transcription activator-like effector nucleases (TALENs): A highly efficient and versatile tool for genome editing. Biotechnol Bioeng, 110, 1811-21.
  24. Tesson L, Usal C, Menoret S, et al (2011). Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol, 29, 695-6.
  25. Urnov FD, Rebar EJ, Holmes MC, et al (2010). Genome editing with engineered zinc finger nucleases. Nat Rev Genet, 11, 636-46.
  26. Wei C, Liu J, Yu Z, et al (2013). TALEN or Cas9 - rapid, efficient and specific choices for genome modifications. J Genet Genomics, 40, 281-9.
  27. Youns MM, Abdel Wahab AH, Hassan ZA, et al (2013). Serum talin-1 is a potential novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Asian Pac J Cancer Prev, 14, 3819-23.